FDA Inspection 947755 — GlaxoSmithKline Vaccines Srl
The FDA completed an inspection of GlaxoSmithKline Vaccines Srl on June 26, 2015 in Sovicille. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 26, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Sovicille (Italy)